Looking Into Harrow Health’s Return On Capital Employed
Harrow Health (NASDAQ:HROW) posted a 7.77% decrease in earnings from Q4. Sales, however, increased by 5.81% over the previous quarter to $15.44 million. Despite the increase in sales this quarter, the decrease in earnings may suggest Harrow Health is not utilizing their capital as effectively as possible.
